May 04, 2020 / 03:00PM GMT
Operator
Good morning, and welcome to the Eli Lilly and Company Annual Meeting of Shareholders. The meeting will now begin.
David A. Ricks - Eli Lilly and Company - Chairman, CEO & President
Good morning. I'm Dave Ricks, Lilly's Chairman and CEO. Thank you for joining us today for our first virtual shareholders meeting, designed to help keep everyone safe during the COVID-19 pandemic. We plan to resume our in-person format next year. And in the meantime, you can submit questions and vote from the virtual meeting site, regardless of your location.
Participating with me today are Josh Smiley, our CFO; Dr. Dan Skovronsky, our Chief Scientific Officer and the President of Lilly Research Labs; Anat Hakim, our General Counsel; Bronwen Mantlo, our Corporate Secretary; and Kevin Hern, our Vice President of Investor Relations. We are also joined virtually by the rest of the Lilly executive officers, our independent directors and representatives from our principal independent accounting firm, Ernst & Young.
If you'd like to follow along, you'll find a
Eli Lilly and Co Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot